fda glp-1 compounding warning september 2025 Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, Semaglutide End FDA Demurs on GLP-1 Compounding

Epub 2025 Feb 25

Reminder: These distinctions come from animal data and anecdotal use, not clinical trials in women

Hyperinsulinemia and chronic inflammation, common in insulin resistance and type 2 diabetes, promote the overexpression and secretion of endothelin-1 (ET-1), a potent endothelium-derived vasoconstrictor

The growing recognition of obesity as a major public health challenge is driving government consideration of structured treatment programs and potential reimbursement frameworks for effective pharmacotherapy

Toward a Mechanistic Understanding of Feo-Mediated Ferrous Iron Uptake

Patients were from the United States, China, Italy, Sweden, Israel, Australia and Taiwan